Data: UK dining habits shift due to weight loss drugs
The rise of weight-loss drugs, including Ozempic and Wegovy, is shifting restaurant takeaway culture across the UK, with more unhealthy dishes declining, according to research from hospitality tech company storekit.
The data found that indulgent items at restaurants, including burgers, fries and shakes, decreased from 19 per cent to less than 9 per cent of all items ordered.
Restaurant orders for burgers and fries fell by 37 per cent and 26 per cent year-on-year, respectively.
Meanwhile, there has been a surge in healthy food products, including protein-forward meals and customisable dishes.
Subscribe to Grocery Gazette for free
Sign up here to get the latest grocery and food news each morning
Christophe Delacroix, co-founder and CEO of storekit said: “This data shows a clear shift in how people are thinking about food. Diners are moving away from heavy, indulgent choices and towards meals that feel lighter, more balanced and better aligned with their health goals.
“The huge growth in bowls, protein-led dishes and customisation – like swapping fries for salad shows people want more control over what they eat and how it fits into their lifestyle.”
The orders for bowls, soups and protein-led dishes have increased by 143 per cent, 186 per cent and 85 per cent, respectively, on an annual basis.
There was also a 344 per cent surge in low/no alcohol orders, and mocktails went up by 190 per cent due to weight-loss drugs suppressing alcohol cravings.
The Build Your Own Bowl orders have increased by 175 per cent, and “swap for salad” modifiers went up by 1,232 per cent.
The insights show that this may be a longer-term consumer shift driven by the rise in popularity of weight loss jabs and health-conscious shopping going mainstream.



